

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 8.02739828 |
| 2 | response to pheromone (GO:0019236) | 7.00405577 |
| 3 | detection of molecule of bacterial origin (GO:0032490) | 5.95243023 |
| 4 | negative regulation of fibrinolysis (GO:0051918) | 5.37596402 |
| 5 | regulation of fibrinolysis (GO:0051917) | 5.17043312 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.87576332 |
| 7 | auditory receptor cell stereocilium organization (GO:0060088) | 4.69564742 |
| 8 | sulfate transmembrane transport (GO:1902358) | 4.66224074 |
| 9 | synaptic vesicle maturation (GO:0016188) | 4.63157644 |
| 10 | glutamate secretion (GO:0014047) | 4.56851855 |
| 11 | cellular anion homeostasis (GO:0030002) | 4.55717992 |
| 12 | energy homeostasis (GO:0097009) | 4.44231572 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.41512724 |
| 14 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.26738102 |
| 15 | L-phenylalanine catabolic process (GO:0006559) | 4.23116845 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.23116845 |
| 17 | G-protein coupled receptor internalization (GO:0002031) | 4.22088304 |
| 18 | regulation of protein activation cascade (GO:2000257) | 4.07501366 |
| 19 | sulfate transport (GO:0008272) | 4.03372895 |
| 20 | detection of external biotic stimulus (GO:0098581) | 3.99318187 |
| 21 | positive regulation of heat generation (GO:0031652) | 3.95227378 |
| 22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.90545000 |
| 23 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.89783798 |
| 24 | L-phenylalanine metabolic process (GO:0006558) | 3.89783798 |
| 25 | exogenous drug catabolic process (GO:0042738) | 3.87987482 |
| 26 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.84316373 |
| 27 | regulation of complement activation (GO:0030449) | 3.82304507 |
| 28 | neurotransmitter secretion (GO:0007269) | 3.81708870 |
| 29 | regulation of fever generation (GO:0031620) | 3.78988946 |
| 30 | intestinal cholesterol absorption (GO:0030299) | 3.76885402 |
| 31 | inner ear receptor stereocilium organization (GO:0060122) | 3.70477868 |
| 32 | drug catabolic process (GO:0042737) | 3.66730800 |
| 33 | protein carboxylation (GO:0018214) | 3.64160562 |
| 34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.64160562 |
| 35 | regulation of plasminogen activation (GO:0010755) | 3.62904845 |
| 36 | phosphate ion homeostasis (GO:0055062) | 3.61079663 |
| 37 | trivalent inorganic anion homeostasis (GO:0072506) | 3.61079663 |
| 38 | complement activation, alternative pathway (GO:0006957) | 3.58312483 |
| 39 | synaptic vesicle exocytosis (GO:0016079) | 3.55295286 |
| 40 | detection of biotic stimulus (GO:0009595) | 3.54848892 |
| 41 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.53174611 |
| 42 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.53137542 |
| 43 | positive regulation of transforming growth factor beta production (GO:0071636) | 3.50439370 |
| 44 | fibrinolysis (GO:0042730) | 3.34259030 |
| 45 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.32332219 |
| 46 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.30784717 |
| 47 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.30520209 |
| 48 | positive regulation of prostaglandin secretion (GO:0032308) | 3.30327726 |
| 49 | blood coagulation, intrinsic pathway (GO:0007597) | 3.29964857 |
| 50 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.29271161 |
| 51 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.29271161 |
| 52 | post-embryonic morphogenesis (GO:0009886) | 3.28871315 |
| 53 | lateral ventricle development (GO:0021670) | 3.27535377 |
| 54 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.23782598 |
| 55 | prostate gland growth (GO:0060736) | 3.22721234 |
| 56 | negative regulation of macroautophagy (GO:0016242) | 3.22025281 |
| 57 | omega-hydroxylase P450 pathway (GO:0097267) | 3.20947468 |
| 58 | glutamate metabolic process (GO:0006536) | 3.18663242 |
| 59 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.18268236 |
| 60 | urea metabolic process (GO:0019627) | 3.17949292 |
| 61 | negative regulation of cholesterol transport (GO:0032375) | 3.17530482 |
| 62 | negative regulation of sterol transport (GO:0032372) | 3.17530482 |
| 63 | positive regulation of icosanoid secretion (GO:0032305) | 3.17463928 |
| 64 | response to parathyroid hormone (GO:0071107) | 3.16311077 |
| 65 | cellular potassium ion homeostasis (GO:0030007) | 3.15308417 |
| 66 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 3.14539192 |
| 67 | aromatic amino acid family catabolic process (GO:0009074) | 3.11628344 |
| 68 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.09577452 |
| 69 | negative regulation of mast cell activation (GO:0033004) | 3.07958113 |
| 70 | C4-dicarboxylate transport (GO:0015740) | 3.05869116 |
| 71 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.05475482 |
| 72 | gamma-aminobutyric acid transport (GO:0015812) | 3.05255607 |
| 73 | regulation of vesicle fusion (GO:0031338) | 3.04257545 |
| 74 | nitrogen cycle metabolic process (GO:0071941) | 3.04096431 |
| 75 | regulation of heat generation (GO:0031650) | 3.03940160 |
| 76 | neuron remodeling (GO:0016322) | 3.02130977 |
| 77 | cholesterol efflux (GO:0033344) | 2.99687235 |
| 78 | glyoxylate metabolic process (GO:0046487) | 2.98748780 |
| 79 | drinking behavior (GO:0042756) | 2.96908393 |
| 80 | neuronal action potential propagation (GO:0019227) | 2.96259802 |
| 81 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.94902216 |
| 82 | regulation of cholesterol esterification (GO:0010872) | 2.94060850 |
| 83 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.92729045 |
| 84 | histone H3-K9 modification (GO:0061647) | 2.92171672 |
| 85 | regulation of activation of Janus kinase activity (GO:0010533) | 2.91772170 |
| 86 | acute-phase response (GO:0006953) | 2.90614496 |
| 87 | synaptic transmission, glutamatergic (GO:0035249) | 2.89565196 |
| 88 | low-density lipoprotein particle remodeling (GO:0034374) | 2.89406665 |
| 89 | opioid receptor signaling pathway (GO:0038003) | 2.89222163 |
| 90 | epoxygenase P450 pathway (GO:0019373) | 2.89066688 |
| 91 | regulation of synaptic vesicle transport (GO:1902803) | 2.89043245 |
| 92 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.87371862 |
| 93 | positive regulation of hemostasis (GO:1900048) | 2.86869569 |
| 94 | positive regulation of blood coagulation (GO:0030194) | 2.86869569 |
| 95 | positive regulation of dendritic spine development (GO:0060999) | 2.85654734 |
| 96 | negative regulation of protein activation cascade (GO:2000258) | 2.85404334 |
| 97 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.84576232 |
| 98 | bile acid biosynthetic process (GO:0006699) | 2.83841611 |
| 99 | negative regulation of T cell mediated immunity (GO:0002710) | 2.83166422 |
| 100 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.82815877 |
| 101 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.82815877 |
| 102 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.82409172 |
| 103 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.82409172 |
| 104 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.82409172 |
| 105 | developmental pigmentation (GO:0048066) | 2.81399349 |
| 106 | oxidative demethylation (GO:0070989) | 2.81057867 |
| 107 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.80732096 |
| 108 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.80156140 |
| 109 | regulation of pigment cell differentiation (GO:0050932) | 2.78762293 |
| 110 | negative regulation of meiosis (GO:0045835) | 2.78401382 |
| 111 | regulation of prostaglandin secretion (GO:0032306) | 2.78384538 |
| 112 | superoxide anion generation (GO:0042554) | 2.77925826 |
| 113 | regulation of circadian sleep/wake cycle (GO:0042749) | 2.77842252 |
| 114 | regulation of circadian sleep/wake cycle, sleep (GO:0045187) | 2.77842252 |
| 115 | positive regulation of coagulation (GO:0050820) | 2.77419725 |
| 116 | positive regulation of vascular permeability (GO:0043117) | 2.75112867 |
| 117 | positive regulation of T cell cytokine production (GO:0002726) | 2.74387234 |
| 118 | modulation by virus of host process (GO:0019054) | 2.74110063 |
| 119 | plasma lipoprotein particle remodeling (GO:0034369) | 2.73130058 |
| 120 | protein-lipid complex remodeling (GO:0034368) | 2.73130058 |
| 121 | macromolecular complex remodeling (GO:0034367) | 2.73130058 |
| 122 | histone H3-K4 trimethylation (GO:0080182) | 2.73086664 |
| 123 | mesenchymal cell differentiation (GO:0048762) | 2.73024680 |
| 124 | phenylpropanoid metabolic process (GO:0009698) | 2.71892013 |
| 125 | histone H3-K36 demethylation (GO:0070544) | 2.71745522 |
| 126 | neurotransmitter transport (GO:0006836) | 2.71150266 |
| 127 | interferon-gamma production (GO:0032609) | 2.70616723 |
| 128 | regulation of icosanoid secretion (GO:0032303) | 2.68556179 |
| 129 | succinate metabolic process (GO:0006105) | 2.66677947 |
| 130 | negative regulation of blood coagulation (GO:0030195) | 2.65182368 |
| 131 | negative regulation of hemostasis (GO:1900047) | 2.65182368 |
| 132 | glycoside metabolic process (GO:0016137) | 2.65028644 |
| 133 | cellular response to ethanol (GO:0071361) | 2.64932451 |
| 134 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.64673448 |
| 135 | monocyte chemotaxis (GO:0002548) | 2.64458437 |
| 136 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.63334383 |
| 137 | urea cycle (GO:0000050) | 2.62991448 |
| 138 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.62933968 |
| 139 | regulation of somitogenesis (GO:0014807) | 2.61151352 |
| 140 | macrophage activation (GO:0042116) | 2.60795965 |
| 141 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.60580061 |
| 142 | S-adenosylmethionine metabolic process (GO:0046500) | 2.59364619 |
| 143 | cell proliferation involved in metanephros development (GO:0072203) | 2.58712895 |
| 144 | glutamate receptor signaling pathway (GO:0007215) | 2.57145132 |
| 145 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.56352001 |
| 146 | neuron-neuron synaptic transmission (GO:0007270) | 2.56059045 |
| 147 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.55796141 |
| 148 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.55741564 |
| 149 | negative regulation of interleukin-12 production (GO:0032695) | 2.55455009 |
| 150 | regulation of neurotransmitter levels (GO:0001505) | 2.54967073 |
| 151 | regulation of germinal center formation (GO:0002634) | 2.54895450 |
| 152 | ganglion development (GO:0061548) | 2.54781544 |
| 153 | steroid catabolic process (GO:0006706) | 2.53290293 |
| 154 | positive regulation of protein sumoylation (GO:0033235) | 2.53188296 |
| 155 | positive regulation of synapse maturation (GO:0090129) | 2.52589806 |
| 156 | cell differentiation involved in metanephros development (GO:0072202) | 2.52410500 |
| 157 | proline transport (GO:0015824) | 2.52400445 |
| 158 | estrogen biosynthetic process (GO:0006703) | 2.51740187 |
| 159 | negative regulation of wound healing (GO:0061045) | 2.51521254 |
| 160 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.51342093 |
| 161 | positive regulation of fatty acid transport (GO:2000193) | 2.49045893 |
| 162 | bile acid metabolic process (GO:0008206) | 2.48795987 |
| 163 | sodium ion export (GO:0071436) | 2.48502542 |
| 164 | cellular extravasation (GO:0045123) | 2.45874489 |
| 165 | cellular response to zinc ion (GO:0071294) | 2.45093801 |
| 166 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.44662893 |
| 167 | regulation of DNA endoreduplication (GO:0032875) | 2.44104717 |
| 168 | regulation of keratinocyte proliferation (GO:0010837) | 2.43056959 |
| 169 | B cell homeostasis (GO:0001782) | 2.42752543 |
| 170 | regulation of humoral immune response (GO:0002920) | 2.42689301 |
| 171 | cell proliferation involved in kidney development (GO:0072111) | 2.41544578 |
| 172 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.40733605 |
| 173 | bone remodeling (GO:0046849) | 2.40671085 |
| 174 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.40155056 |
| 175 | negative regulation of coagulation (GO:0050819) | 2.40145190 |
| 176 | positive regulation by symbiont of host defense response (GO:0052509) | 2.39783676 |
| 177 | modulation by symbiont of host defense response (GO:0052031) | 2.39783676 |
| 178 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.39783676 |
| 179 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.39783676 |
| 180 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.39783676 |
| 181 | modulation by symbiont of host immune response (GO:0052553) | 2.39783676 |
| 182 | extracellular regulation of signal transduction (GO:1900115) | 2.39032561 |
| 183 | extracellular negative regulation of signal transduction (GO:1900116) | 2.39032561 |
| 184 | negative regulation of response to nutrient levels (GO:0032108) | 2.38167607 |
| 185 | negative regulation of response to extracellular stimulus (GO:0032105) | 2.38167607 |
| 186 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.37828289 |
| 187 | fat-soluble vitamin catabolic process (GO:0042363) | 2.36425576 |
| 188 | vitamin catabolic process (GO:0009111) | 2.36425576 |
| 189 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.36363806 |
| 190 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.34203871 |
| 191 | response to host immune response (GO:0052572) | 2.34203871 |
| 192 | mesonephros development (GO:0001823) | 2.33729348 |
| 193 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.32620446 |
| 194 | daunorubicin metabolic process (GO:0044597) | 12.7524545 |
| 195 | polyketide metabolic process (GO:0030638) | 12.7524545 |
| 196 | doxorubicin metabolic process (GO:0044598) | 12.7524545 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.93838532 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.67182980 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.27012906 |
| 4 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.25867289 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.17677887 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.86847606 |
| 7 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.52947072 |
| 8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.52788414 |
| 9 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.52275980 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.48483455 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.44401357 |
| 12 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.30370252 |
| 13 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.26530919 |
| 14 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.24125173 |
| 15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.14185977 |
| 16 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 2.13177622 |
| 17 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.99093584 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.97890089 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.93071358 |
| 20 | P300_19829295_ChIP-Seq_ESCs_Human | 1.91208086 |
| 21 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.89464162 |
| 22 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.89456660 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.89361282 |
| 24 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.85521432 |
| 25 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.85349669 |
| 26 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.85069169 |
| 27 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.83817636 |
| 28 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.83212406 |
| 29 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.82726944 |
| 30 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.81888446 |
| 31 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.80962633 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.79652003 |
| 33 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.78562828 |
| 34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.78376007 |
| 35 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.77978534 |
| 36 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.77073966 |
| 37 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.74741159 |
| 38 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.73927160 |
| 39 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.72405984 |
| 40 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.72301634 |
| 41 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.71209881 |
| 42 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.69950717 |
| 43 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.68482335 |
| 44 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.66313963 |
| 45 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.65086261 |
| 46 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.64862306 |
| 47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.64714941 |
| 48 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.60385750 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58690822 |
| 50 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.58481294 |
| 51 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.54883503 |
| 52 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.54289250 |
| 53 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.53016664 |
| 54 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.52075000 |
| 55 | EWS_26573619_Chip-Seq_HEK293_Human | 1.51729096 |
| 56 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.51654188 |
| 57 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.51360232 |
| 58 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.49565960 |
| 59 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.48249380 |
| 60 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.46561422 |
| 61 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.45366920 |
| 62 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.45336308 |
| 63 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.44764035 |
| 64 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.44579964 |
| 65 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.44408914 |
| 66 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.44248859 |
| 67 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.43626037 |
| 68 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.43336653 |
| 69 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.43336653 |
| 70 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.42829815 |
| 71 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.42700616 |
| 72 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.42392270 |
| 73 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.41858316 |
| 74 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.41781101 |
| 75 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.41697646 |
| 76 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.39917302 |
| 77 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.39342234 |
| 78 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.39329871 |
| 79 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37640371 |
| 80 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.37225271 |
| 81 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.37139356 |
| 82 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.37076189 |
| 83 | VDR_22108803_ChIP-Seq_LS180_Human | 1.36656631 |
| 84 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36301583 |
| 85 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.36301583 |
| 86 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.35406887 |
| 87 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.35371538 |
| 88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.33289195 |
| 89 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.32572361 |
| 90 | STAT3_23295773_ChIP-Seq_U87_Human | 1.31855579 |
| 91 | RXR_22108803_ChIP-Seq_LS180_Human | 1.31028731 |
| 92 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.30896766 |
| 93 | FUS_26573619_Chip-Seq_HEK293_Human | 1.30818362 |
| 94 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.30472767 |
| 95 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.28283059 |
| 96 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.28247448 |
| 97 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.27564121 |
| 98 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.26771632 |
| 99 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.25676020 |
| 100 | GATA1_22025678_ChIP-Seq_K562_Human | 1.25479101 |
| 101 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.24800344 |
| 102 | TCF4_23295773_ChIP-Seq_U87_Human | 1.24471365 |
| 103 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24459457 |
| 104 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23501028 |
| 105 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.23287442 |
| 106 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20222591 |
| 107 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.19181335 |
| 108 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.17122291 |
| 109 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16848668 |
| 110 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16783606 |
| 111 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.16020000 |
| 112 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.15220917 |
| 113 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.14975127 |
| 114 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.14713772 |
| 115 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.14166996 |
| 116 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.12548277 |
| 117 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.11941976 |
| 118 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.11605552 |
| 119 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11118694 |
| 120 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.10996433 |
| 121 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.10237360 |
| 122 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09049059 |
| 123 | KDM2B_26808549_Chip-Seq_REH_Human | 1.06799344 |
| 124 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.06564691 |
| 125 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.06461741 |
| 126 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.06382027 |
| 127 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.04441609 |
| 128 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.04190913 |
| 129 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.04070595 |
| 130 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.04070595 |
| 131 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02703270 |
| 132 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.02612289 |
| 133 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02594100 |
| 134 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.00463424 |
| 135 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.00463424 |
| 136 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.99730602 |
| 137 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.97679869 |
| 138 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97390138 |
| 139 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.97293778 |
| 140 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95968461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.21603072 |
| 2 | MP0000566_synostosis | 4.67677766 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 4.18280312 |
| 4 | MP0005645_abnormal_hypothalamus_physiol | 3.83234810 |
| 5 | MP0005257_abnormal_intraocular_pressure | 3.64341452 |
| 6 | MP0002277_abnormal_respiratory_mucosa | 3.63173414 |
| 7 | MP0008004_abnormal_stomach_pH | 3.53401265 |
| 8 | MP0006292_abnormal_olfactory_placode | 3.50954160 |
| 9 | MP0003878_abnormal_ear_physiology | 3.50358929 |
| 10 | MP0005377_hearing/vestibular/ear_phenot | 3.50358929 |
| 11 | MP0003195_calcinosis | 3.32758790 |
| 12 | MP0005365_abnormal_bile_salt | 3.12145687 |
| 13 | MP0000569_abnormal_digit_pigmentation | 3.07106871 |
| 14 | MP0009697_abnormal_copulation | 3.03470764 |
| 15 | MP0001986_abnormal_taste_sensitivity | 2.99866789 |
| 16 | MP0003880_abnormal_central_pattern | 2.96954001 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.86052043 |
| 18 | MP0001188_hyperpigmentation | 2.46268861 |
| 19 | MP0003635_abnormal_synaptic_transmissio | 2.45826921 |
| 20 | MP0005646_abnormal_pituitary_gland | 2.44936233 |
| 21 | MP0002163_abnormal_gland_morphology | 2.33048799 |
| 22 | MP0003252_abnormal_bile_duct | 2.32154949 |
| 23 | MP0002064_seizures | 2.28923417 |
| 24 | MP0003941_abnormal_skin_development | 2.23703948 |
| 25 | MP0009745_abnormal_behavioral_response | 2.23236459 |
| 26 | MP0002938_white_spotting | 2.19253506 |
| 27 | MP0005171_absent_coat_pigmentation | 2.11727525 |
| 28 | MP0008875_abnormal_xenobiotic_pharmacok | 2.09454715 |
| 29 | MP0004270_analgesia | 2.09025916 |
| 30 | MP0000678_abnormal_parathyroid_gland | 2.08128716 |
| 31 | MP0002063_abnormal_learning/memory/cond | 2.07381530 |
| 32 | MP0002396_abnormal_hematopoietic_system | 2.06661866 |
| 33 | MP0001348_abnormal_lacrimal_gland | 2.00583766 |
| 34 | MP0000604_amyloidosis | 2.00123789 |
| 35 | MP0002272_abnormal_nervous_system | 1.92799136 |
| 36 | MP0001346_abnormal_lacrimal_gland | 1.84122473 |
| 37 | MP0002638_abnormal_pupillary_reflex | 1.83769695 |
| 38 | MP0005085_abnormal_gallbladder_physiolo | 1.79246723 |
| 39 | MP0005379_endocrine/exocrine_gland_phen | 1.78350875 |
| 40 | MP0003329_amyloid_beta_deposits | 1.78222348 |
| 41 | MP0010386_abnormal_urinary_bladder | 1.77445436 |
| 42 | MP0004742_abnormal_vestibular_system | 1.64622223 |
| 43 | MP0009840_abnormal_foam_cell | 1.64565696 |
| 44 | MP0003633_abnormal_nervous_system | 1.63542565 |
| 45 | MP0003787_abnormal_imprinting | 1.58022150 |
| 46 | MP0000015_abnormal_ear_pigmentation | 1.57719804 |
| 47 | MP0003879_abnormal_hair_cell | 1.57275528 |
| 48 | MP0001666_abnormal_nutrient_absorption | 1.56159734 |
| 49 | MP0002102_abnormal_ear_morphology | 1.56103252 |
| 50 | MP0003303_peritoneal_inflammation | 1.54371475 |
| 51 | MP0006276_abnormal_autonomic_nervous | 1.54027641 |
| 52 | MP0005423_abnormal_somatic_nervous | 1.51878109 |
| 53 | MP0001486_abnormal_startle_reflex | 1.49285803 |
| 54 | MP0005310_abnormal_salivary_gland | 1.47886551 |
| 55 | MP0005409_darkened_coat_color | 1.46516960 |
| 56 | MP0003868_abnormal_feces_composition | 1.45025256 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 1.44920100 |
| 58 | MP0003283_abnormal_digestive_organ | 1.40834380 |
| 59 | MP0010329_abnormal_lipoprotein_level | 1.39025798 |
| 60 | MP0002735_abnormal_chemical_nociception | 1.38324188 |
| 61 | MP0000013_abnormal_adipose_tissue | 1.30053512 |
| 62 | MP0003690_abnormal_glial_cell | 1.29470432 |
| 63 | MP0001542_abnormal_bone_strength | 1.28578365 |
| 64 | MP0005174_abnormal_tail_pigmentation | 1.28258377 |
| 65 | MP0000920_abnormal_myelination | 1.26932016 |
| 66 | MP0002998_abnormal_bone_remodeling | 1.26255110 |
| 67 | MP0002132_abnormal_respiratory_system | 1.25198234 |
| 68 | MP0000681_abnormal_thyroid_gland | 1.23350734 |
| 69 | MP0008569_lethality_at_weaning | 1.22824991 |
| 70 | MP0003075_altered_response_to | 1.22669054 |
| 71 | MP0003045_fibrosis | 1.20985129 |
| 72 | MP0003631_nervous_system_phenotype | 1.18867229 |
| 73 | MP0005671_abnormal_response_to | 1.18403693 |
| 74 | MP0008874_decreased_physiological_sensi | 1.15807605 |
| 75 | MP0004811_abnormal_neuron_physiology | 1.15521101 |
| 76 | MP0005386_behavior/neurological_phenoty | 1.15096640 |
| 77 | MP0004924_abnormal_behavior | 1.15096640 |
| 78 | MP0002734_abnormal_mechanical_nocicepti | 1.13877475 |
| 79 | MP0010368_abnormal_lymphatic_system | 1.13682870 |
| 80 | MP0004142_abnormal_muscle_tone | 1.09251449 |
| 81 | MP0001835_abnormal_antigen_presentation | 1.06764767 |
| 82 | MP0002067_abnormal_sensory_capabilities | 1.04021624 |
| 83 | MP0003122_maternal_imprinting | 1.03283929 |
| 84 | MP0002095_abnormal_skin_pigmentation | 1.03178858 |
| 85 | MP0001485_abnormal_pinna_reflex | 1.02279988 |
| 86 | MP0003136_yellow_coat_color | 1.02138626 |
| 87 | MP0002148_abnormal_hypersensitivity_rea | 1.01599762 |
| 88 | MP0005503_abnormal_tendon_morphology | 1.01174409 |
| 89 | MP0005387_immune_system_phenotype | 1.01041299 |
| 90 | MP0001790_abnormal_immune_system | 1.01041299 |
| 91 | MP0001501_abnormal_sleep_pattern | 1.00139386 |
| 92 | MP0002876_abnormal_thyroid_physiology | 1.00106904 |
| 93 | MP0005332_abnormal_amino_acid | 1.00010184 |
| 94 | MP0000372_irregular_coat_pigmentation | 0.99929520 |
| 95 | MP0005535_abnormal_body_temperature | 0.99136818 |
| 96 | MP0000049_abnormal_middle_ear | 0.97680478 |
| 97 | MP0000609_abnormal_liver_physiology | 0.97212009 |
| 98 | MP0002557_abnormal_social/conspecific_i | 0.95396996 |
| 99 | MP0002249_abnormal_larynx_morphology | 0.94879198 |
| 100 | MP0002733_abnormal_thermal_nociception | 0.93891013 |
| 101 | MP0002075_abnormal_coat/hair_pigmentati | 0.93561960 |
| 102 | MP0001970_abnormal_pain_threshold | 0.93049362 |
| 103 | MP0003300_gastrointestinal_ulcer | 0.92581628 |
| 104 | MP0005075_abnormal_melanosome_morpholog | 0.92275020 |
| 105 | MP0005167_abnormal_blood-brain_barrier | 0.91949788 |
| 106 | MP0001186_pigmentation_phenotype | 0.89217076 |
| 107 | MP0002066_abnormal_motor_capabilities/c | 0.88239441 |
| 108 | MP0002118_abnormal_lipid_homeostasis | 0.88188164 |
| 109 | MP0005084_abnormal_gallbladder_morpholo | 0.87874215 |
| 110 | MP0002896_abnormal_bone_mineralization | 0.87158759 |
| 111 | MP0001915_intracranial_hemorrhage | 0.84399262 |
| 112 | MP0002177_abnormal_outer_ear | 0.83185252 |
| 113 | MP0009250_abnormal_appendicular_skeleto | 0.82893198 |
| 114 | MP0001963_abnormal_hearing_physiology | 0.81443892 |
| 115 | MP0001293_anophthalmia | 0.80617839 |
| 116 | MP0002109_abnormal_limb_morphology | 0.80418913 |
| 117 | MP0002419_abnormal_innate_immunity | 0.80261217 |
| 118 | MP0001764_abnormal_homeostasis | 0.80251957 |
| 119 | MP0002837_dystrophic_cardiac_calcinosis | 0.79202632 |
| 120 | MP0000778_abnormal_nervous_system | 0.78700199 |
| 121 | MP0001984_abnormal_olfaction | 0.78580609 |
| 122 | MP0001529_abnormal_vocalization | 0.77701598 |
| 123 | MP0006035_abnormal_mitochondrial_morpho | 0.77031973 |
| 124 | MP0008438_abnormal_cutaneous_collagen | 0.76884411 |
| 125 | MP0004381_abnormal_hair_follicle | 0.76656460 |
| 126 | MP0003634_abnormal_glial_cell | 0.75914246 |
| 127 | MP0002909_abnormal_adrenal_gland | 0.74567751 |
| 128 | MP0001324_abnormal_eye_pigmentation | 0.74006000 |
| 129 | MP0002113_abnormal_skeleton_development | 0.73868739 |
| 130 | MP0002572_abnormal_emotion/affect_behav | 0.73407053 |
| 131 | MP0003436_decreased_susceptibility_to | 0.73356421 |
| 132 | MP0003121_genomic_imprinting | 0.72780356 |
| 133 | MP0002229_neurodegeneration | 0.72205597 |
| 134 | MP0001299_abnormal_eye_distance/ | 0.71819834 |
| 135 | MP0001440_abnormal_grooming_behavior | 0.70792774 |
| 136 | MP0002693_abnormal_pancreas_physiology | 0.69923161 |
| 137 | MP0006036_abnormal_mitochondrial_physio | 0.69241050 |
| 138 | MP0001800_abnormal_humoral_immune | 0.68668095 |
| 139 | MP0008469_abnormal_protein_level | 0.68534033 |
| 140 | MP0009764_decreased_sensitivity_to | 0.68058939 |
| 141 | MP0003806_abnormal_nucleotide_metabolis | 0.67293403 |
| 142 | MP0002928_abnormal_bile_duct | 0.67127316 |
| 143 | MP0005451_abnormal_body_composition | 0.67025046 |
| 144 | MP0000631_abnormal_neuroendocrine_gland | 0.66942483 |
| 145 | MP0003795_abnormal_bone_structure | 0.66842282 |
| 146 | MP0000026_abnormal_inner_ear | 0.66757356 |
| 147 | MP0002736_abnormal_nociception_after | 0.66733502 |
| 148 | MP0001533_abnormal_skeleton_physiology | 0.66495871 |
| 149 | MP0003959_abnormal_lean_body | 0.65993703 |
| 150 | MP0002452_abnormal_antigen_presenting | 0.65871665 |
| 151 | MP0001502_abnormal_circadian_rhythm | 0.65671531 |
| 152 | MP0000613_abnormal_salivary_gland | 0.63866901 |
| 153 | MP0000470_abnormal_stomach_morphology | 0.63852720 |
| 154 | MP0001968_abnormal_touch/_nociception | 0.63516577 |
| 155 | MP0002723_abnormal_immune_serum | 0.63207915 |
| 156 | MP0003172_abnormal_lysosome_physiology | 0.60847692 |
| 157 | MP0002233_abnormal_nose_morphology | 0.60762597 |
| 158 | MP0005390_skeleton_phenotype | 0.60470026 |
| 159 | MP0002116_abnormal_craniofacial_bone | 0.60317859 |
| 160 | MP0002098_abnormal_vibrissa_morphology | 0.59651708 |
| 161 | MP0009046_muscle_twitch | 0.59188814 |
| 162 | MP0004782_abnormal_surfactant_physiolog | 0.58819747 |
| 163 | MP0001119_abnormal_female_reproductive | 0.58279365 |
| 164 | MP0002184_abnormal_innervation | 0.57585058 |
| 165 | MP0004134_abnormal_chest_morphology | 0.57395913 |
| 166 | MP0001819_abnormal_immune_cell | 0.56582914 |
| 167 | MP0005000_abnormal_immune_tolerance | 0.56033680 |
| 168 | MP0005367_renal/urinary_system_phenotyp | 0.55671832 |
| 169 | MP0000516_abnormal_urinary_system | 0.55671832 |
| 170 | MP0003385_abnormal_body_wall | 0.55571155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Papilledema (HP:0001085) | 6.14440985 |
| 2 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 5.72865419 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.43323114 |
| 4 | Unilateral renal agenesis (HP:0000122) | 5.05373494 |
| 5 | Parakeratosis (HP:0001036) | 4.95692762 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.69469915 |
| 7 | Cheilitis (HP:0100825) | 4.28368950 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 4.20339877 |
| 9 | Absent eyebrow (HP:0002223) | 4.15429236 |
| 10 | Prostate neoplasm (HP:0100787) | 4.09285528 |
| 11 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.04673936 |
| 12 | Alopecia of scalp (HP:0002293) | 3.92718254 |
| 13 | Hypophosphatemic rickets (HP:0004912) | 3.82745208 |
| 14 | Follicular hyperkeratosis (HP:0007502) | 3.80985191 |
| 15 | Complement deficiency (HP:0004431) | 3.72474693 |
| 16 | Hypobetalipoproteinemia (HP:0003563) | 3.71914268 |
| 17 | Abnormality of dental color (HP:0011073) | 3.69733332 |
| 18 | Chromsome breakage (HP:0040012) | 3.62441199 |
| 19 | Epileptic encephalopathy (HP:0200134) | 3.55445902 |
| 20 | Metaphyseal dysplasia (HP:0100255) | 3.48856288 |
| 21 | Atonic seizures (HP:0010819) | 3.34891133 |
| 22 | Patchy hypopigmentation of hair (HP:0011365) | 3.33030501 |
| 23 | Absent/shortened dynein arms (HP:0200106) | 3.30803140 |
| 24 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.30803140 |
| 25 | Absence seizures (HP:0002121) | 3.19122099 |
| 26 | White forelock (HP:0002211) | 3.11072577 |
| 27 | Focal seizures (HP:0007359) | 3.08508334 |
| 28 | Hyperphosphatemia (HP:0002905) | 3.08357107 |
| 29 | Absent eyelashes (HP:0000561) | 3.05861552 |
| 30 | Osteomalacia (HP:0002749) | 3.05198334 |
| 31 | Bilateral sensorineural hearing impairment (HP:0008619) | 3.05159070 |
| 32 | Congenital sensorineural hearing impairment (HP:0008527) | 3.02308688 |
| 33 | Abnormality of incisor morphology (HP:0011063) | 3.00340437 |
| 34 | Myokymia (HP:0002411) | 2.98265898 |
| 35 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.96902318 |
| 36 | Scanning speech (HP:0002168) | 2.96343307 |
| 37 | Supranuclear gaze palsy (HP:0000605) | 2.95128156 |
| 38 | Febrile seizures (HP:0002373) | 2.93668604 |
| 39 | Recurrent corneal erosions (HP:0000495) | 2.82137276 |
| 40 | Chronic hepatic failure (HP:0100626) | 2.78390855 |
| 41 | Torticollis (HP:0000473) | 2.74678805 |
| 42 | Ectropion (HP:0000656) | 2.65570078 |
| 43 | Focal dystonia (HP:0004373) | 2.64892451 |
| 44 | Hyperlipoproteinemia (HP:0010980) | 2.64739407 |
| 45 | Insidious onset (HP:0003587) | 2.63491670 |
| 46 | Termporal pattern (HP:0011008) | 2.63491670 |
| 47 | Craniofacial dystonia (HP:0012179) | 2.63352214 |
| 48 | Septo-optic dysplasia (HP:0100842) | 2.63234586 |
| 49 | Aplasia cutis congenita (HP:0001057) | 2.62158084 |
| 50 | Spontaneous abortion (HP:0005268) | 2.60609539 |
| 51 | Abnormality of complement system (HP:0005339) | 2.60503504 |
| 52 | Alveolar cell carcinoma (HP:0006519) | 2.59663148 |
| 53 | Joint hemorrhage (HP:0005261) | 2.57881805 |
| 54 | Action tremor (HP:0002345) | 2.57261302 |
| 55 | Dialeptic seizures (HP:0011146) | 2.57210804 |
| 56 | Ectopic kidney (HP:0000086) | 2.55974475 |
| 57 | Rickets (HP:0002748) | 2.51511235 |
| 58 | Abnormality of the renal collecting system (HP:0004742) | 2.51024426 |
| 59 | Abnormality of the corticospinal tract (HP:0002492) | 2.44975630 |
| 60 | Metaphyseal irregularity (HP:0003025) | 2.44242570 |
| 61 | Generalized tonic-clonic seizures (HP:0002069) | 2.44036779 |
| 62 | Duplicated collecting system (HP:0000081) | 2.41616951 |
| 63 | Mutism (HP:0002300) | 2.41446789 |
| 64 | Recurrent pneumonia (HP:0006532) | 2.39895260 |
| 65 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.37089633 |
| 66 | Renal dysplasia (HP:0000110) | 2.36262689 |
| 67 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.33282476 |
| 68 | Abnormal ciliary motility (HP:0012262) | 2.32974097 |
| 69 | Abnormality of the common coagulation pathway (HP:0010990) | 2.30961515 |
| 70 | Abnormality of the intrinsic pathway (HP:0010989) | 2.30919507 |
| 71 | Tetany (HP:0001281) | 2.27731321 |
| 72 | Abnormality of the prostate (HP:0008775) | 2.27544607 |
| 73 | Increased density of long bones (HP:0006392) | 2.27350719 |
| 74 | Steatorrhea (HP:0002570) | 2.26755517 |
| 75 | Spastic gait (HP:0002064) | 2.25927355 |
| 76 | Neurofibrillary tangles (HP:0002185) | 2.24898246 |
| 77 | Status epilepticus (HP:0002133) | 2.23841824 |
| 78 | Chronic diarrhea (HP:0002028) | 2.23572171 |
| 79 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.22263930 |
| 80 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.22263930 |
| 81 | Large eyes (HP:0001090) | 2.21982995 |
| 82 | Retrobulbar optic neuritis (HP:0100654) | 2.21071414 |
| 83 | Optic neuritis (HP:0100653) | 2.21071414 |
| 84 | Tetraparesis (HP:0002273) | 2.18380124 |
| 85 | Neoplasm of the lung (HP:0100526) | 2.16855173 |
| 86 | Epidermoid cyst (HP:0200040) | 2.15827880 |
| 87 | Recurrent cutaneous fungal infections (HP:0011370) | 2.14639889 |
| 88 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.14639889 |
| 89 | Agammaglobulinemia (HP:0004432) | 2.13570465 |
| 90 | Decreased central vision (HP:0007663) | 2.12823996 |
| 91 | Chronic otitis media (HP:0000389) | 2.12667905 |
| 92 | Abnormality of the parietal bone (HP:0002696) | 2.12391052 |
| 93 | Arthropathy (HP:0003040) | 2.12262025 |
| 94 | Mild short stature (HP:0003502) | 2.11902912 |
| 95 | Abnormality of binocular vision (HP:0011514) | 2.11671714 |
| 96 | Diplopia (HP:0000651) | 2.11671714 |
| 97 | Small epiphyses (HP:0010585) | 2.10657621 |
| 98 | Microvesicular hepatic steatosis (HP:0001414) | 2.10271386 |
| 99 | Abnormality of the vertebral endplates (HP:0005106) | 2.08395874 |
| 100 | Midline defect of the nose (HP:0004122) | 2.08343059 |
| 101 | Keratitis (HP:0000491) | 2.07511587 |
| 102 | True hermaphroditism (HP:0010459) | 2.07468960 |
| 103 | Fat malabsorption (HP:0002630) | 2.07339312 |
| 104 | Postural tremor (HP:0002174) | 2.05956516 |
| 105 | Broad ribs (HP:0000885) | 2.05857437 |
| 106 | Urinary urgency (HP:0000012) | 2.04999468 |
| 107 | Epileptiform EEG discharges (HP:0011182) | 2.02989197 |
| 108 | Pancreatic fibrosis (HP:0100732) | 2.02011217 |
| 109 | Xanthomatosis (HP:0000991) | 2.01022790 |
| 110 | Hyperactive renin-angiotensin system (HP:0000841) | 2.00956568 |
| 111 | Abnormality of the intervertebral disk (HP:0005108) | 2.00801571 |
| 112 | Conical tooth (HP:0000698) | 2.00706889 |
| 113 | Overgrowth (HP:0001548) | 2.00031770 |
| 114 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.99377241 |
| 115 | Abnormality of proline metabolism (HP:0010907) | 1.98386896 |
| 116 | Hydroxyprolinuria (HP:0003080) | 1.98386896 |
| 117 | Impaired vibratory sensation (HP:0002495) | 1.98061309 |
| 118 | Clubbing of toes (HP:0100760) | 1.97936092 |
| 119 | Hip dysplasia (HP:0001385) | 1.97117454 |
| 120 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.96368378 |
| 121 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.96368378 |
| 122 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.95307301 |
| 123 | Conjugated hyperbilirubinemia (HP:0002908) | 1.95207734 |
| 124 | Bone pain (HP:0002653) | 1.95014600 |
| 125 | Enlarged epiphyses (HP:0010580) | 1.93638944 |
| 126 | Systemic lupus erythematosus (HP:0002725) | 1.92903490 |
| 127 | Abnormality of the right ventricle (HP:0001707) | 1.92354933 |
| 128 | EEG with generalized epileptiform discharges (HP:0011198) | 1.92244022 |
| 129 | Hypothermia (HP:0002045) | 1.91641253 |
| 130 | Glomerulonephritis (HP:0000099) | 1.89830244 |
| 131 | Depression (HP:0000716) | 1.89653504 |
| 132 | Abnormality of the nasal septum (HP:0000419) | 1.89594323 |
| 133 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.85744601 |
| 134 | Lip pit (HP:0100267) | 1.85507121 |
| 135 | Amelogenesis imperfecta (HP:0000705) | 1.85481969 |
| 136 | Hypergonadotropic hypogonadism (HP:0000815) | 1.85414013 |
| 137 | Absent hair (HP:0002298) | 1.85379881 |
| 138 | Popliteal pterygium (HP:0009756) | 1.84569784 |
| 139 | Joint swelling (HP:0001386) | 1.84231867 |
| 140 | Oligodontia (HP:0000677) | 1.82794541 |
| 141 | Submucous cleft hard palate (HP:0000176) | 1.82016404 |
| 142 | Cutaneous finger syndactyly (HP:0010554) | 1.81847036 |
| 143 | Abnormality of DNA repair (HP:0003254) | 1.80195851 |
| 144 | Oligohydramnios (HP:0001562) | 1.79893554 |
| 145 | Paraplegia (HP:0010550) | 1.77939864 |
| 146 | Small hand (HP:0200055) | 1.76696618 |
| 147 | Neoplasm of the respiratory system (HP:0100606) | 1.75236027 |
| 148 | Autoamputation (HP:0001218) | 1.74945101 |
| 149 | Bile duct proliferation (HP:0001408) | 1.74599220 |
| 150 | Abnormal biliary tract physiology (HP:0012439) | 1.74599220 |
| 151 | Hypsarrhythmia (HP:0002521) | 1.74349511 |
| 152 | Renal cortical cysts (HP:0000803) | 1.74309133 |
| 153 | Abnormality of the preputium (HP:0100587) | 1.73089634 |
| 154 | Elevated alkaline phosphatase (HP:0003155) | 1.72237664 |
| 155 | Insomnia (HP:0100785) | 1.72224412 |
| 156 | Blepharitis (HP:0000498) | 1.72150409 |
| 157 | Erythroderma (HP:0001019) | 1.71610777 |
| 158 | Recurrent abscess formation (HP:0002722) | 1.71531309 |
| 159 | Abolished electroretinogram (ERG) (HP:0000550) | 1.71309851 |
| 160 | Orchitis (HP:0100796) | 1.71130713 |
| 161 | Spondylolisthesis (HP:0003302) | 1.70689346 |
| 162 | Hypolipoproteinemia (HP:0010981) | 1.70588747 |
| 163 | Generalized aminoaciduria (HP:0002909) | 1.69645872 |
| 164 | Anxiety (HP:0000739) | 1.69067927 |
| 165 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.67622097 |
| 166 | Truncal ataxia (HP:0002078) | 1.67429869 |
| 167 | Increased number of teeth (HP:0011069) | 1.67316560 |
| 168 | Hemiparesis (HP:0001269) | 1.67211464 |
| 169 | Impaired smooth pursuit (HP:0007772) | 1.66515300 |
| 170 | Orthostatic hypotension (HP:0001278) | 1.65798108 |
| 171 | Visual hallucinations (HP:0002367) | 1.65729575 |
| 172 | Recurrent lower respiratory tract infections (HP:0002783) | 1.65616568 |
| 173 | Abnormality of the incisor (HP:0000676) | 1.65566445 |
| 174 | Gingival bleeding (HP:0000225) | 1.65188886 |
| 175 | Craniofacial hyperostosis (HP:0004493) | 1.64881399 |
| 176 | Peripheral hypomyelination (HP:0007182) | 1.64611454 |
| 177 | Irregular vertebral endplates (HP:0003301) | 1.64194361 |
| 178 | Abnormal eating behavior (HP:0100738) | 1.64021633 |
| 179 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.63574843 |
| 180 | Limb dystonia (HP:0002451) | 1.63469996 |
| 181 | Fair hair (HP:0002286) | 1.63274212 |
| 182 | Lower limb muscle weakness (HP:0007340) | 1.63106625 |
| 183 | Hypoplastic iliac wings (HP:0002866) | 1.62951642 |
| 184 | Pulmonary embolism (HP:0002204) | 1.62799392 |
| 185 | Convex nasal ridge (HP:0000444) | 1.61203035 |
| 186 | Hyperaldosteronism (HP:0000859) | 1.60629439 |
| 187 | Mitral stenosis (HP:0001718) | 1.60399226 |
| 188 | Focal motor seizures (HP:0011153) | 1.59716877 |
| 189 | Widely spaced teeth (HP:0000687) | 1.59002358 |
| 190 | Metabolic alkalosis (HP:0200114) | 1.58758005 |
| 191 | Renal agenesis (HP:0000104) | 1.58604751 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK3 | 7.33709108 |
| 2 | SIK2 | 4.22267072 |
| 3 | SIK1 | 3.42616978 |
| 4 | EPHA4 | 3.15681723 |
| 5 | CDK8 | 3.03440617 |
| 6 | PAK6 | 2.93596593 |
| 7 | TXK | 2.77979763 |
| 8 | MARK1 | 2.73119972 |
| 9 | MAP3K9 | 2.67261080 |
| 10 | NEK9 | 2.58892997 |
| 11 | INSRR | 2.57436709 |
| 12 | DAPK2 | 2.53627202 |
| 13 | MARK3 | 2.51228196 |
| 14 | MAP3K4 | 2.49908295 |
| 15 | CAMKK2 | 2.11161025 |
| 16 | PINK1 | 2.09463991 |
| 17 | ZAK | 2.06874439 |
| 18 | TNIK | 2.02348879 |
| 19 | EIF2AK1 | 2.00495722 |
| 20 | NTRK2 | 1.97666141 |
| 21 | CASK | 1.94859276 |
| 22 | NTRK1 | 1.93987973 |
| 23 | LATS1 | 1.86371133 |
| 24 | MAP3K14 | 1.85973224 |
| 25 | KSR2 | 1.84038973 |
| 26 | MAP3K11 | 1.80809910 |
| 27 | ADRBK2 | 1.76754235 |
| 28 | CAMKK1 | 1.73668358 |
| 29 | SCYL2 | 1.62871244 |
| 30 | GRK7 | 1.61437853 |
| 31 | DAPK1 | 1.58441148 |
| 32 | EIF2AK2 | 1.52593814 |
| 33 | RAF1 | 1.50475439 |
| 34 | STK38L | 1.48546150 |
| 35 | TAOK1 | 1.36920453 |
| 36 | CDK3 | 1.35585506 |
| 37 | CDK12 | 1.34988237 |
| 38 | UHMK1 | 1.28433585 |
| 39 | ARAF | 1.27670935 |
| 40 | NUAK1 | 1.27472060 |
| 41 | MAPK13 | 1.26224719 |
| 42 | TNK2 | 1.26107583 |
| 43 | MAP2K7 | 1.25897889 |
| 44 | SGK2 | 1.25723378 |
| 45 | TGFBR2 | 1.25170608 |
| 46 | MAP2K4 | 1.23339586 |
| 47 | NTRK3 | 1.22759297 |
| 48 | PRPF4B | 1.20989244 |
| 49 | IRAK3 | 1.20438207 |
| 50 | IRAK4 | 1.19320544 |
| 51 | SRPK1 | 1.19319831 |
| 52 | TEC | 1.18806387 |
| 53 | EIF2AK3 | 1.16333351 |
| 54 | ALK | 1.16217424 |
| 55 | MINK1 | 1.16136247 |
| 56 | MAP3K5 | 1.13984985 |
| 57 | YES1 | 1.09643003 |
| 58 | PRKCG | 1.09294717 |
| 59 | MKNK2 | 1.06504664 |
| 60 | CDK5 | 1.05786887 |
| 61 | PIM2 | 1.05568564 |
| 62 | ERN1 | 1.02105826 |
| 63 | CAMK1D | 1.01322471 |
| 64 | MAP3K1 | 1.00112046 |
| 65 | BMPR1B | 0.99401580 |
| 66 | FGFR3 | 0.98902366 |
| 67 | PRKCH | 0.97332489 |
| 68 | MARK2 | 0.97229004 |
| 69 | RIPK4 | 0.93809371 |
| 70 | PDK1 | 0.93039245 |
| 71 | CSNK1G2 | 0.92178473 |
| 72 | MAP3K13 | 0.91735600 |
| 73 | RIPK1 | 0.90805314 |
| 74 | CAMK1G | 0.90477435 |
| 75 | BMPR2 | 0.89442743 |
| 76 | STK3 | 0.89328757 |
| 77 | PIK3CA | 0.82597176 |
| 78 | CSNK1A1L | 0.82172439 |
| 79 | AKT3 | 0.81590637 |
| 80 | JAK3 | 0.80985718 |
| 81 | EPHA2 | 0.80506747 |
| 82 | DDR2 | 0.79707393 |
| 83 | CAMK1 | 0.79398227 |
| 84 | LATS2 | 0.78763737 |
| 85 | MOS | 0.78217690 |
| 86 | IKBKB | 0.77752258 |
| 87 | KIT | 0.76852479 |
| 88 | CSNK1G3 | 0.75530613 |
| 89 | PIK3CG | 0.73182528 |
| 90 | WNK1 | 0.72413765 |
| 91 | PDGFRA | 0.69266108 |
| 92 | FGFR4 | 0.68938654 |
| 93 | CAMK4 | 0.68460004 |
| 94 | KSR1 | 0.68138162 |
| 95 | PBK | 0.67687226 |
| 96 | SGK3 | 0.67467446 |
| 97 | VRK1 | 0.67452318 |
| 98 | CAMK2A | 0.67255392 |
| 99 | CDK7 | 0.67157689 |
| 100 | FES | 0.63863532 |
| 101 | FRK | 0.63676988 |
| 102 | BRD4 | 0.63639336 |
| 103 | TAOK3 | 0.63375357 |
| 104 | MAP2K6 | 0.63348701 |
| 105 | CHUK | 0.63227088 |
| 106 | NLK | 0.62685303 |
| 107 | JAK1 | 0.61130493 |
| 108 | PDPK1 | 0.60235136 |
| 109 | ATR | 0.60173747 |
| 110 | NEK6 | 0.59125168 |
| 111 | IRAK2 | 0.59115253 |
| 112 | MAP3K6 | 0.57984298 |
| 113 | TBK1 | 0.57753829 |
| 114 | CHEK2 | 0.57090124 |
| 115 | IRAK1 | 0.56363748 |
| 116 | BLK | 0.56354909 |
| 117 | MAPK10 | 0.56073319 |
| 118 | MAPK12 | 0.56056555 |
| 119 | LYN | 0.55642444 |
| 120 | SGK223 | 0.55483584 |
| 121 | SGK494 | 0.55483584 |
| 122 | PRKAA2 | 0.55028018 |
| 123 | PLK4 | 0.54667272 |
| 124 | MAP3K12 | 0.54305771 |
| 125 | ITK | 0.54020764 |
| 126 | CDK14 | 0.53724203 |
| 127 | MAPK7 | 0.52785127 |
| 128 | MAPK11 | 0.52652370 |
| 129 | PLK2 | 0.52423779 |
| 130 | RPS6KB1 | 0.49133393 |
| 131 | PAK3 | 0.48908799 |
| 132 | IKBKE | 0.48532497 |
| 133 | CDK15 | 0.48338643 |
| 134 | CAMK2B | 0.47118241 |
| 135 | TYRO3 | 0.47103412 |
| 136 | JAK2 | 0.47078894 |
| 137 | CSNK1G1 | 0.46681950 |
| 138 | MKNK1 | 0.46541227 |
| 139 | ABL2 | 0.46035015 |
| 140 | EPHA3 | 0.45715399 |
| 141 | RPS6KA3 | 0.45405799 |
| 142 | CDK11A | 0.44714211 |
| 143 | MATK | 0.44572290 |
| 144 | PRKACG | 0.44395506 |
| 145 | STK16 | 0.43986155 |
| 146 | SGK1 | 0.42560227 |
| 147 | PRKCE | 0.42559500 |
| 148 | CCNB1 | 0.41804999 |
| 149 | TAOK2 | 0.41232930 |
| 150 | CDK18 | 0.41202403 |
| 151 | PRKG1 | 0.40883102 |
| 152 | PRKCB | 0.39588263 |
| 153 | MUSK | 0.39225467 |
| 154 | CSNK1E | 0.39124380 |
| 155 | MAPK15 | 0.38355108 |
| 156 | STK38 | 0.38017344 |
| 157 | BCR | 0.37849952 |
| 158 | TIE1 | 0.37396157 |
| 159 | SYK | 0.36942089 |
| 160 | HCK | 0.35900139 |
| 161 | GRK1 | 0.33107376 |
| 162 | AKT1 | 0.29832371 |
| 163 | RPS6KA5 | 0.29166770 |
| 164 | ATM | 0.28738485 |
| 165 | PRKCQ | 0.27334567 |
| 166 | CSNK1D | 0.26289199 |
| 167 | BTK | 0.25798046 |
| 168 | PKN1 | 0.25482359 |
| 169 | PRKAA1 | 0.25029060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.95329626 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.86604093 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.26705498 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.66982726 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.61261661 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.47720208 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.18139168 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 2.12373925 |
| 9 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.04423267 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.02235420 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.94317415 |
| 12 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.94211797 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.88186715 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 1.86794344 |
| 15 | Prion diseases_Homo sapiens_hsa05020 | 1.82029670 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.76002754 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.75006201 |
| 18 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.73245943 |
| 19 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.71541131 |
| 20 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.67603942 |
| 21 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.67523747 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.65382609 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.64096598 |
| 24 | Taste transduction_Homo sapiens_hsa04742 | 1.62373283 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.59302400 |
| 26 | Long-term potentiation_Homo sapiens_hsa04720 | 1.58416151 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.54700737 |
| 28 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.53435273 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50794853 |
| 30 | Basal transcription factors_Homo sapiens_hsa03022 | 1.49765930 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.49354100 |
| 32 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.49198510 |
| 33 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.48759975 |
| 34 | Mineral absorption_Homo sapiens_hsa04978 | 1.46702070 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.42950414 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.41627075 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.41318934 |
| 38 | Homologous recombination_Homo sapiens_hsa03440 | 1.40978078 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.38436574 |
| 40 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.37513246 |
| 41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.35685498 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.34294281 |
| 43 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.33243673 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.30279966 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 1.27183755 |
| 46 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.27147443 |
| 47 | Melanoma_Homo sapiens_hsa05218 | 1.24457137 |
| 48 | Morphine addiction_Homo sapiens_hsa05032 | 1.23686985 |
| 49 | Leishmaniasis_Homo sapiens_hsa05140 | 1.22669593 |
| 50 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.22201801 |
| 51 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.21716220 |
| 52 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.21039535 |
| 53 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.20628641 |
| 54 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.19389817 |
| 55 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.19041018 |
| 56 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.17833986 |
| 57 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.14690159 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.13418846 |
| 59 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12847373 |
| 60 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.12677724 |
| 61 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.09909466 |
| 62 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.09036177 |
| 63 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.07805194 |
| 64 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.07705466 |
| 65 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.07660716 |
| 66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.07470421 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.06729358 |
| 68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.06282825 |
| 69 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.06145790 |
| 70 | Allograft rejection_Homo sapiens_hsa05330 | 1.05783560 |
| 71 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.04534686 |
| 72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.03502178 |
| 73 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.03407789 |
| 74 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.98993733 |
| 75 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.97986594 |
| 76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.97303010 |
| 77 | Influenza A_Homo sapiens_hsa05164 | 0.96344707 |
| 78 | Phototransduction_Homo sapiens_hsa04744 | 0.96269153 |
| 79 | Olfactory transduction_Homo sapiens_hsa04740 | 0.95462938 |
| 80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.95343540 |
| 81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92641269 |
| 82 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.92100470 |
| 83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.91740801 |
| 84 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.90454555 |
| 85 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.89001466 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88632687 |
| 87 | Tuberculosis_Homo sapiens_hsa05152 | 0.87598853 |
| 88 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.87573076 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.87100356 |
| 90 | Long-term depression_Homo sapiens_hsa04730 | 0.86673797 |
| 91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.84122107 |
| 92 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.82300608 |
| 93 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.81837244 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80881946 |
| 95 | Axon guidance_Homo sapiens_hsa04360 | 0.80600094 |
| 96 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79875543 |
| 97 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.78983700 |
| 98 | Insulin secretion_Homo sapiens_hsa04911 | 0.78175869 |
| 99 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76815535 |
| 100 | Circadian entrainment_Homo sapiens_hsa04713 | 0.73310451 |
| 101 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.73245786 |
| 102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73178195 |
| 103 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.71843356 |
| 104 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.71428119 |
| 105 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71222647 |
| 106 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70814930 |
| 107 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.69767157 |
| 108 | Hepatitis B_Homo sapiens_hsa05161 | 0.69567103 |
| 109 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.68671334 |
| 110 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.67960424 |
| 111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67935154 |
| 112 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66868707 |
| 113 | Phagosome_Homo sapiens_hsa04145 | 0.66773299 |
| 114 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65444120 |
| 115 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.64147911 |
| 116 | Malaria_Homo sapiens_hsa05144 | 0.64050389 |
| 117 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62778958 |
| 118 | Circadian rhythm_Homo sapiens_hsa04710 | 0.62442833 |
| 119 | Pertussis_Homo sapiens_hsa05133 | 0.61781033 |
| 120 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.60173469 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60040274 |
| 122 | Prostate cancer_Homo sapiens_hsa05215 | 0.59560122 |
| 123 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59553606 |
| 124 | Renin secretion_Homo sapiens_hsa04924 | 0.57748861 |
| 125 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57329964 |
| 126 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56734512 |
| 127 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.56116898 |
| 128 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.56024772 |
| 129 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.55100079 |
| 130 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52679726 |
| 131 | Protein export_Homo sapiens_hsa03060 | 0.52495313 |
| 132 | Asthma_Homo sapiens_hsa05310 | 0.52259238 |
| 133 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51771647 |
| 134 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51684007 |
| 135 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.51683957 |
| 136 | Cocaine addiction_Homo sapiens_hsa05030 | 0.49990989 |
| 137 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49508360 |
| 138 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.49319974 |
| 139 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.48729594 |
| 140 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48686808 |
| 141 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.48420951 |
| 142 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.48265230 |
| 143 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48090433 |
| 144 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.47723955 |
| 145 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.47401532 |
| 146 | Histidine metabolism_Homo sapiens_hsa00340 | 0.46576690 |
| 147 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.46271639 |
| 148 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.45777772 |
| 149 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45358305 |
| 150 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.44964579 |
| 151 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44916700 |
| 152 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.44867596 |
| 153 | Hepatitis C_Homo sapiens_hsa05160 | 0.44721291 |
| 154 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44648876 |
| 155 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43641800 |
| 156 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.43554124 |
| 157 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.42883000 |
| 158 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.42540991 |
| 159 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42440357 |
| 160 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.39842635 |
| 161 | Glioma_Homo sapiens_hsa05214 | 0.39411101 |
| 162 | Carbon metabolism_Homo sapiens_hsa01200 | 0.38418002 |
| 163 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.36595810 |
| 164 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.33937968 |
| 165 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.33292494 |
| 166 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30391005 |
| 167 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30116644 |
| 168 | ABC transporters_Homo sapiens_hsa02010 | 0.30017795 |
| 169 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29097398 |
| 170 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.26973290 |

